VOMITOL-MD-4mg

Vomitol-MD-4mg is an effective medication designed for complete control of nausea and vomiting. It contains Ondansetron 4 mg in mouth dissolving tablet form, offering quick and convenient administration without the need for water. This product is stocked in a quantity of 508 units, each priced at ₹40 with GST included at ₹44.8, and carries a Maximum Retail Price (MRP) of ₹50. It is valid until December 2026, ensuring long shelf life for safe and reliable use.

Indications:
Vomitol-MD-4mg is primarily indicated for the management of nausea and vomiting caused by various conditions, including postoperative nausea and vomiting (PONV), viral infections, gastroenteritis, drug-induced nausea, and chemotherapy-related vomiting.

Key Features:

• Control: Provides single-dose control of emesis in 93% of patients, ensuring effective relief with minimal dosing.

• Efficacy: Contains an effective concentration of 90% Ondansetron and 33% Metoclopramide for enhanced antiemetic activity.

• Compliance: The mouth dissolving tablet form enhances patient compliance by reducing vomiting with just one dose.

• Safety: Unlike other antiemetics, Vomitol-MD-4mg has no extrapyramidal symptoms (EPS), making it safer for patients.

The product is competitively priced with a Price to Stockist (PTS) of ₹32.14 and Price to Retailer (PTR) of ₹37.71, supporting smooth distribution across channels. With a total stock value of ₹24,794, Vomitol-MD-4mg remains an essential item in pharmaceutical inventories, trusted by healthcare providers for its quality and efficacy.